Skip to content

Research on Hairfall in Unani System of Medicine

Efficacy of oral and topical unani formulations in Telogen Effluvium (Intithar al-shaâ??r)- A randomized single blind comparative clinical study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053580
Enrollment
40
Registered
2023-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L650- Telogen effluvium

Interventions

Intervention1: Itrifal Kishneezi and Roghan Baiza Murgh: Group B will be treated with Itrifal Kishneezi 10g twice daily with Roghan Baiza Murgh 10ml locally on scalp daily followed up after every 15 d

Sponsors

NATIONAL INSTITUTE OF UNANI MEDICINE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed cases of Telogen effluvium (Intithar al-shaâ??r) 2. Females, between age of 18-60 years. 3. Cases of Telogen Effluvium precipitated by following conditions such as typhoid, other febrile illness, major surgery, psychological stress, nutritional deficiencies and crash dieting.

Exclusion criteria

Exclusion criteria: 1.Patients 60 yrs. 2.Patients having disease like scalp psoriasis, tinea capitis, seborrheic dermatitis. 3.Patients having scarring alopecia or other type of non-scarring alopecia. 4.Pregnant and lactating women. 5.Patients suffering from DM, Malignancy. 6.Patients on therapy for TE within a period of 30 days. 7.History of any surgical correction of scalp hair loss.

Design outcomes

Primary

MeasureTime frame
Hair shedding Visual Scale Trichoscopy Timepoint: assessed on baseline 0th day, 15th day, 30th day and 45th day.

Secondary

MeasureTime frame
Hair pull test1 Investigator Assessment using PhotographTimepoint: assessed on baseline 0th day, 15th day, 30th day & 45th day.

Countries

India

Contacts

Public ContactDr Mohd Arshad Jamal

National Institute of Unani Medicine

sarimnium@gmail.com7767993333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026